Nom du produit:2-Chloro-4-(1H-Pyrazol-5-Yl)Benzonitrile
IUPAC Name:2-chloro-4-(1H-pyrazol-5-yl)benzonitrile
- CAS：1297537-37-1
- Formule moléculaire：C10H6ClN3
- Pureté：98%
- Numéro de catalogue：CM336286
- Poids moléculaire：203.63
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1297537-37-1
- Formule moléculaire:C10H6ClN3
- Point de fusion:-
- Code SMILES:N#CC1=CC=C(C2=CC=NN2)C=C1Cl
- Densité:
- Numéro de catalogue:CM336286
- Poids moléculaire:203.63
- Point d'ébullition:
- N° Mdl:
- Stockage:Keep in a tight container and store at ambient temperature
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
- New
- Custom Organic Synthesis,Where to Buy Chemical Building Blocks - Chemenu
- Pharmaceutical intermediates, bulk products, chiral, achiral, heterocycles, metal catalysts, amino acids, peptides, benzene, pyridine, pyrazine, triazine, piperidine, piperazine, morpholine, imidazoline, cyclopropane, indole, benzotriazole, anthranil, quinoline, naphthalene, boronic compounds, fluorination, oxidation, rearrangement reaction
- Chemenu product lines cover amino acids and peptides, heterocyclic compounds, alkanes and aromatic compounds, carbohydrates, alcohols, aldehydes & ketones, pyridazines, metal catalysts and other pharmaceutical intermediates. For more custom organic synthesis, please contact us for a quote.
Column Infos
- Darolutamide
- Bayer announced that its Phase 3 clinical ARANOTE trial met its primary endpoint. Its oral androgen receptor inhibitor (ARi) NUBEQA® (darolutamide) combined with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). NUBEQA® (darolutamide) is an oral androgen receptor inhibitor with a distinct chemical structure that binds to androgen receptors with high affinity and exhibits strong antagonistic activity, thereby inhibiting receptor function and the growth of prostate cancer cells.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
